Association of SARS-CoV-2 seropositive antibody test with risk of future infection
What The Study Did: Researchers use a large set of clinical laboratory data linked to other clinical information such as claims to investigate the relationship between SARS-CoV-2 antibody status and subsequent nucleic acid amplification test (NAAT) results in an effort to understand how serostatus may predict risk of reinfection.
Authors: Lynne T. Penberthy, M.D., M.P.H., of the National Cancer Institute at the National Institutes of Health in Rockville, Maryland, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https:/
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Media advisory: The full study and editor’s note are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https:/
JAMA Network Media Relations